This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
How often have you read, “There are small scattered foci of signal abnormalities (T2 hyperintensities or increased FLAIR signal) in the cerebral white matter indicative of demyelinating disease, chronic white matter ischemia due to microvascular disease, or gliosis from an infectious/inflammatory disease process,” or words just like them in your MRI reports of your elderly patients with cognitive complaints? With this information in hand, do you find yourself struggling to decide how to properly care for your patient: Is this finding clinically relevant? Is it treatable?
We have struggled since at least the early 1900s, when Otto Binswanger described encephalitis chronica progressivea to understand the etiology underlying what we all commonly see reported today on MRI as white matter signal abnormalities. Histologically, Binswanger disease has been associated with changes in the axons and their overlying myelin sheaths resulting in gliosis; this is a consequence of a regional loss or change to the blood supply to the white matter of the brain.1 However, data are scarce that support the notion that the same process could account for the more restricted findings we often see …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Topics Discussed
Alert Me
Recommended articles
Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function
White matter abnormalities and cognition in patients with conflicting diagnoses and CSF profiles
Impact of C-Reactive Protein on Cognition and Alzheimer Disease Biomarkers in Homozygous APOE ɛ4 Carriers
CNS small vessel disease